SORIATANE Side Effects

5958933-0 | Dry Skin, Erythema, Lip Dry, Pain In Extremity, Pulmonary Thrombosis
on Nov 11, 2008 Female patient from UNITED STATES , 55 years of age, weighting 222.0 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: dry skin, erythema, lip dry, pain in extremity, pulmonary thrombosis. Soriatane dosage: 25 Mg;bid;po. During the same period patient was treated with PREMPRO (Qd;po) (View Prempro Review and Prempro Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ELAVIL (View Elavil Review and Elavil Label ). Patient was hospitalized.

5956189-6 | Oesophageal Haemorrhage, Vomiting
Patient was taking Soriatane (View Usage). Patient had the following side effects: oesophageal haemorrhage, vomiting on Nov 05, 2008 from UNITED STATES Additional patient health information: Female patient , 68 years of age, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg; Biw; Po. Patient was hospitalized.

5927326-4 | Caesarean Section, Headache, Hypertension, Pregnancy, Pregnancy On Contraceptive, Treatment Noncompliance
Adverse event was reported on Oct 12, 2008 by a Female patient taking Soriatane (View Usage) (Dosage: 25 Mg; Hs; Po) was diagnosed with psoriasis and. Location: UNITED STATES , 35 years of age, weighting 170.0 lb, After Soriatane was administered, patient had the following side effects: caesarean section, headache (What is headache?), hypertension, pregnancy (What is pregnancy?), pregnancy on contraceptive, treatment noncompliance.

5888236-4 | Abortion Spontaneous, Breech Delivery, Pregnancy, Pregnancy On Oral Contraceptive, Prolonged Pregnancy
on Aug 19, 2008 Female patient from UNITED KINGDOM , 41 years of age, was diagnosed with ichthyosis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous, breech delivery, pregnancy (What is pregnancy?), pregnancy on oral contraceptive, prolonged pregnancy. Soriatane dosage: 35 Mg; Qd; Po,; Po. During the same period patient was treated with CONTRACEPTIVES NOS (View Contraceptives Nos Review and Contraceptives Nos Label ).


5888235-2 | Breech Presentation, Cerebral Cyst, Multiple Congenital Abnormalities, Single Umbilical Artery
on Aug 19, 2008 Female patient from UNITED KINGDOM , weighting 7.50 lb, was treated with Soriatane (View Usage). Patient had the following side effects: breech presentation, cerebral cyst, multiple congenital abnormalities, single umbilical artery. Soriatane dosage: ; Trpl.

5887053-9 | Bradycardia, Pneumonitis
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: bradycardia, pneumonitis on Sep 02, 2008 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with pustular psoriasis, tachycardia and. Soriatane dosage: 25 Mg Daily; Oral. During the same period patient was treated with AMIODARONE HCL (200 Mg, Oral) (View Amiodarone Hcl Review and Amiodarone Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), NITRENDIPINE (NITRENDIPINE) (View Nitrendipine (nitrendipine) Review and Nitrendipine (nitrendipine) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), TRINITRINE (NITROGLYCERIN) (View Trinitrine (nitroglycerin) Review and Trinitrine (nitroglycerin) Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ). Patient was hospitalized.

5879073-5 | Abdominal Pain Upper, Angiopathy, Anorexia, Asthenia, Calcinosis, Diverticulitis, Endoscopy Gastrointestinal Abnormal, Hepatic Cirrhosis, Hepatic Failure
Adverse event was reported on Sep 10, 2008 by a Male patient taking Soriatane (View Usage) (Dosage: 20 Mg Daily Oral) was diagnosed with psoriasis and. Location: FRANCE , 58 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, angiopathy, anorexia, asthenia, calcinosis, diverticulitis, endoscopy gastrointestinal abnormal, hepatic cirrhosis, hepatic failure. During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ). Patient was hospitalized.

5877307-4 | Blood Triglycerides Increased, Musculoskeletal Pain, Pyelonephritis, White Blood Cell Count Increased
on Aug 22, 2008 Female patient from UNITED KINGDOM , 34 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: blood triglycerides increased, musculoskeletal pain, pyelonephritis, white blood cell count increased. Soriatane dosage: 20 Mg;qd;po;po.

5860594-6 | Syncope
on Aug 12, 2008 Female patient from UNITED STATES , 56 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: syncope. Soriatane dosage: 10 Mg;qd;po. During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), PREVACID (View Prevacid Review and Prevacid Label ), PLAVIX (View Plavix Review and Plavix Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5852525-X | Headache, Suicidal Ideation
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), suicidal ideation on Aug 20, 2008 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 242.0 lb, was diagnosed with psoriasis and. Soriatane dosage: 1 Capsule 1 X Day Other.

5846008-0 | Caesarean Section, Hypertension, Pregnancy On Contraceptive
Adverse event was reported on Aug 05, 2008 by a Female patient taking Soriatane (View Usage) (Dosage: 25 Mg; Hs; Po, 25 Mg; Hs; Po, 25 Mg; Hs; Po) was diagnosed with psoriasis and. Location: UNITED STATES , 35 years of age, weighting 170.0 lb, Patient had the following side effects: caesarean section, hypertension, pregnancy on contraceptive.

5839511-0 | Arthralgia, Osteoporosis
on Jul 24, 2008 Male patient from UNITED KINGDOM , 55 years of age, weighting 154.3 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: arthralgia, osteoporosis (What is osteoporosis?). Soriatane dosage: 10 Mg; Qd; Po, ; Po.

5835321-9 | Amnesia, Ascites, Breast Cancer Metastatic, Breast Cancer Recurrent, Confusional State, Constipation, Decreased Appetite, Depression
on Jul 29, 2008 Female patient from UNITED STATES , 65 years of age, weighting 165.0 lb, was diagnosed with squamous cell carcinoma, immunosuppression, neuropathy peripheral, tooth fracture and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, ascites, breast cancer metastatic, breast cancer recurrent, confusional state, constipation (What is constipation?), decreased appetite, depression (What is depression?). Soriatane dosage: 25 Mg; Po, 25 Mg;tiw;po. During the same period patient was treated with NEORAL (Po) (View Neoral Review and Neoral Label ), ALCOHOL (3 L) (View Alcohol Review and Alcohol Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), VICODIN (View Vicodin Review and Vicodin Label ), NITROUS OXIDE W/ OXYGEN (X1) (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ).

5835209-3 | Abortion Induced, Foetal Malformation, Pregnancy
Patient was taking Soriatane (View Usage). Patient had the following side effects: abortion induced, foetal malformation, pregnancy (What is pregnancy?) on Jul 23, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 17 years of age, . Soriatane dosage: 10 Mg; Qd; Po.

5818527-4 | Alcohol Use, Amnesia, Ascites, Breast Cancer Metastatic, Condition Aggravated, Confusional State, Constipation, Decreased Appetite, Depression
Adverse event was reported on Jul 11, 2008 by a Female patient taking Soriatane (View Usage) (Dosage: 25 Mg, Po, 25 Mg;tiw;po) was diagnosed with squamous cell carcinoma, immunosuppression, neuropathy peripheral, tooth fracture and. Location: UNITED STATES , 65 years of age, weighting 165.0 lb, After Soriatane was administered, patient had the following side effects: alcohol use, amnesia, ascites, breast cancer metastatic, condition aggravated, confusional state, constipation (What is constipation?), decreased appetite, depression (What is depression?). During the same period patient was treated with NEORAL (Po, Po) (View Neoral Review and Neoral Label ), ALCOHOL (3 L;) (View Alcohol Review and Alcohol Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

5810628-X | No Adverse Event, Pregnancy
on Jun 26, 2008 Female patient from UNITED STATES , 31 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event, pregnancy (What is pregnancy?). Soriatane dosage: 25 Mg; Qd; Po; 25 Mg; Bid; Po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5808173-0 | Abdominal Distension, Alcohol Use, Amnesia, Confusional State, Decreased Appetite, Diarrhoea, Dry Mouth
on Jun 30, 2008 Female patient from UNITED STATES , 65 years of age, weighting 165.0 lb, was diagnosed with squamous cell carcinoma, immunosuppression, neuropathy peripheral, tooth fracture and was treated with Soriatane (View Usage). Patient had the following side effects: abdominal distension, alcohol use, amnesia, confusional state, decreased appetite, diarrhoea, dry mouth. Soriatane dosage: 25 Mg; Po; 25 Mg; Tiw; Po. During the same period patient was treated with NEORAL (Po; Po;) (View Neoral Review and Neoral Label ), ALCOHOL (3 L) (View Alcohol Review and Alcohol Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), VICODIN (View Vicodin Review and Vicodin Label ). Patient was hospitalized.

5808170-5 | Pregnancy
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: pregnancy (What is pregnancy?) on Jun 26, 2008 from UNITED STATES Additional patient health information: Female patient , 31 years of age, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg; Qd; Po, 25 Mg; Bid; Po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5788774-9 | Alcohol Use, Pregnancy
Adverse event was reported on Jun 11, 2008 by a Female patient taking Soriatane (View Usage) (Dosage: 10 Mg; Qd; Po) was diagnosed with keratosis follicular and. Location: UNITED KINGDOM , 22 years of age, Patient experienced the following unwanted or unexpected effects: alcohol use, pregnancy (What is pregnancy?).

5776073-0 | Alcohol Use, Pregnancy
on Jun 03, 2008 Female patient from UNITED KINGDOM , 22 years of age, was diagnosed with keratosis follicular and was treated with Soriatane (View Usage). Patient had the following side effects: alcohol use, pregnancy (What is pregnancy?). Soriatane dosage: 10 Mg; Qd; Po.

5765703-5 | Alcohol Use, Blood Creatinine Increased, Blood Urea Increased, Confusional State, Renal Failure Acute
on May 30, 2008 Female patient from UNITED STATES , 65 years of age, weighting 165.0 lb, was diagnosed with squamous cell carcinoma, immunosuppression, neuropathy peripheral, tooth fracture and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: alcohol use, blood creatinine increased, blood urea increased, confusional state, renal failure acute. Soriatane dosage: 25 Mg; Po; 25 Mg; Tiw; Po. During the same period patient was treated with NEORAL (Po; Po) (View Neoral Review and Neoral Label ), ALCOHOL (3 L;) (View Alcohol Review and Alcohol Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), VICODIN (View Vicodin Review and Vicodin Label ), NITROUS OXIDE W/ OXYGEN (X1;) (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ). Patient was hospitalized.

5765663-7 | Abasia, Arthralgia, Arthritis, Asthenia, Ataxia, Condition Aggravated, Conjunctivitis, Joint Swelling, Muscular Weakness
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: abasia, arthralgia, arthritis (What is arthritis?), asthenia, ataxia (What is ataxia?), condition aggravated, conjunctivitis, joint swelling, muscular weakness on May 29, 2008 from UNITED STATES Additional patient health information: Female patient , 51 years of age, weighting 210.0 lb, was diagnosed with pityriasis rubra pilaris and. Soriatane dosage: 25 Mg; Bid; Po. During the same period patient was treated with VERSAFOAM (Bid; Top) (View Versafoam Review and Versafoam Label ), ATARAX (View Atarax Review and Atarax Label ), CLOBETASOL PROPIONATE (View Clobetasol Propionate Review and Clobetasol Propionate Label ), AMLACTIN CREAM (View Amlactin Cream Review and Amlactin Cream Label ), UMECTA (View Umecta Review and Umecta Label ). Patient was hospitalized.

5758077-7 | Arthralgia, Asthenia, Ataxia, Condition Aggravated, Joint Swelling, Off Label Use, Rash
Adverse event was reported on May 16, 2008 by a Female patient taking Soriatane (View Usage) (Dosage: 25 Mg; Bid; Po, 25 Mg; Po) was diagnosed with pityriasis rubra pilaris and. Location: UNITED STATES , 51 years of age, weighting 210.0 lb, Patient had the following side effects: arthralgia, asthenia, ataxia (What is ataxia?), condition aggravated, joint swelling, off label use, rash (What is rash?). During the same period patient was treated with VERSAFOAM (Bid; Top) (View Versafoam Review and Versafoam Label ), ATARAX (View Atarax Review and Atarax Label ), CLOBETASOL PROPIONATE (View Clobetasol Propionate Review and Clobetasol Propionate Label ), AMLACTIN CREAM (View Amlactin Cream Review and Amlactin Cream Label ), UMECTA (View Umecta Review and Umecta Label ). Patient was hospitalized.

5748890-4 | Alcohol Use, Asthenia, Balance Disorder, Condition Aggravated, Confusional State, Diabetic Ketoacidosis, Haemodialysis, Hyperlipidaemia, Multi-organ Failure
on May 14, 2008 Male patient from FRANCE , 47 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: alcohol use, asthenia, balance disorder, condition aggravated, confusional state, diabetic ketoacidosis, haemodialysis, hyperlipidaemia, multi-organ failure. Soriatane dosage: Po. During the same period patient was treated with ALCOHOL (ETHANOL) (View Alcohol (ethanol) Review and Alcohol (ethanol) Label ), FIBRATES (View Fibrates Review and Fibrates Label ). Patient was hospitalized.

5732546-8 | Pregnancy
on Apr 23, 2008 Female patient from UNITED KINGDOM , 30 years of age, was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?). Soriatane dosage: 35 Mg;qd;po : 25 Mg;qd;po.

5701680-0 | Abdominal Pain Upper, Activities Of Daily Living Impaired, Alopecia, Anorexia, Diarrhoea, Gait Disturbance, Headache, Hypertriglyceridaemia, Nausea
Patient was taking Soriatane (View Usage). Patient had the following side effects: abdominal pain upper, activities of daily living impaired, alopecia, anorexia, diarrhoea, gait disturbance, headache (What is headache?), hypertriglyceridaemia, nausea (What is nausea?) on Mar 31, 2008 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 595.2 lb, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg; Bid; Po. During the same period patient was treated with ACCUPRIL (View Accupril Review and Accupril Label ), CLONIDINE HCL (View Clonidine Hcl Review and Clonidine Hcl Label ), PROPAFENONE HCL (View Propafenone Hcl Review and Propafenone Hcl Label ), KLOR CON (View Klor-con Review and Klor-con Label ), THEO 24 (View Theo-24 Review and Theo-24 Label ), PREMARIN (View Premarin Review and Premarin Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5688136-9 | Congenital Cerebral Cyst, Umbilical Cord Vascular Disorder
Adverse event was reported on Mar 14, 2008 by a Female patient taking Soriatane (View Usage) (Dosage: 35 Mg; Qd; Po; Po) was diagnosed with ichthyosis and. Location: UNITED KINGDOM , 41 years of age, After Soriatane was administered, patient had the following side effects: congenital cerebral cyst, umbilical cord vascular disorder. During the same period patient was treated with CONTRACEPTIVE NOS (View Contraceptive Nos Review and Contraceptive Nos Label ).

5680772-9 | Anaemia
on Mar 10, 2008 Male patient from UNITED STATES , 53 years of age, was diagnosed with nephrogenic anaemia, renal transplant and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia. Soriatane dosage: Po. During the same period patient was treated with PROCRIT (80000 Iu; Qw) (View Procrit Review and Procrit Label ), PROGRAF (View Prograf Review and Prograf Label ), SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ), IMMUNOSUPPRESSIVE AGENTS (View Immunosuppressive Agents Review and Immunosuppressive Agents Label ).

5663736-0 | Abnormal Behaviour, Confusional State
on Jan 28, 2008 Female patient from FRANCE , 63 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: abnormal behaviour, confusional state. Soriatane dosage: 20 Mg Daily Oral. During the same period patient was treated with MELADININE (METHOXSALEN) (1 Dose Form 3 Per Week Oral) (View Meladinine (methoxsalen) Review and Meladinine (methoxsalen) Label ). Patient was hospitalized.

5663735-9 | Blood Lactate Dehydrogenase Increased, Condition Aggravated, Dermatitis Exfoliative, Eosinophilia, Gamma-glutamyltransferase Increased, Lymphadenopathy, No Therapeutic Response, Oedema Peripheral, Psoriasis
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: blood lactate dehydrogenase increased, condition aggravated, dermatitis exfoliative, eosinophilia, gamma-glutamyltransferase increased, lymphadenopathy, no therapeutic response, oedema peripheral, psoriasis on Feb 14, 2008 from FRANCE Additional patient health information: Male patient , 45 years of age, . Soriatane dosage: Oral. During the same period patient was treated with RHINUREFLEX (IBUPROFEN/PSEUDOEPHEDRINE HYDROCHLORIDE) (View Rhinureflex (ibuprofen/pseudoephedrine Hydrochloride) Review and Rhinureflex (ibuprofen/pseudoephedrine Hydrochloride) Label ), MUCICLAR (*AMBROXOL/*CARBOCYSTEINE) (View Muciclar (*ambroxol/*carbocysteine) Review and Muciclar (*ambroxol/*carbocysteine) Label ), BRONCHODUAL (FENOTEROL/IPRATROPIUM BROMIDE) (View Bronchodual (fenoterol/ipratropium Bromide) Review and Bronchodual (fenoterol/ipratropium Bromide) Label ). Patient was hospitalized.

5658006-0 | Gait Disturbance, Hepatic Enzyme Increased
Adverse event was reported on Feb 18, 2008 by a Male patient taking Soriatane (View Usage) (Dosage: 25 Mg; Qd; Po; 25 Mg; Qod; Po) was diagnosed with psoriasis and. Location: UNITED STATES , 14 years of age, Patient experienced the following unwanted or unexpected effects: gait disturbance, hepatic enzyme increased. During the same period patient was treated with CLARITIN D (View Claritin-d Review and Claritin-d Label ), PSEUDOEPHEDRINE HCL (View Pseudoephedrine Hcl Review and Pseudoephedrine Hcl Label ).

5631351-0 | Grand Mal Convulsion
on Feb 07, 2008 Male patient from UNITED STATES , 39 years of age, weighting 150.0 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: grand mal convulsion. Soriatane dosage: 25 Mg; Qd; Po. Patient was hospitalized.

5630293-4 | Pregnancy
on Feb 04, 2008 Female patient from UNITED STATES , 29 years of age, was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: pregnancy (What is pregnancy?). Soriatane dosage: Po. During the same period patient was treated with BIRTH CONTRL PILLS NOS (View Birth Contrl Pills Nos Review and Birth Contrl Pills Nos Label ).

5624204-5 | Grand Mal Convulsion
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion on Jan 31, 2008 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 150.0 lb, was diagnosed with psoriasis and. Soriatane dosage: Qd; Po. Patient was hospitalized.

5614667-3 | Bile Duct Obstruction, Cholelithiasis, Headache, Rash Macular, Skin Disorder, Skin Inflammation
Adverse event was reported on Jan 23, 2008 by a Male patient taking Soriatane (View Usage) (Dosage: 25 Mg; Qd; Po) was diagnosed with psoriasis, blood cholesterol increased and. Location: UNITED STATES , 62 years of age, weighting 260.0 lb, Patient had the following side effects: bile duct obstruction, cholelithiasis, headache (What is headache?), rash macular, skin disorder, skin inflammation. During the same period patient was treated with LIPITOR (; Po) (View Lipitor Review and Lipitor Label ), LIDEX (View Lidex Review and Lidex Label ), PREVACID (View Prevacid Review and Prevacid Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ). Patient was hospitalized.

5604119-9 | Pregnancy
on Jan 16, 2008 Female patient from UNITED STATES , 31 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: pregnancy (What is pregnancy?). Soriatane dosage: 25 Mg;qd;po, 25 Mg;bid;po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

5600347-7 | Cerebrovascular Accident
on May 17, 2007 Female patient from UNITED STATES , 55 years of age, weighting 247.0 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident. Soriatane dosage: 25 Mg;qd;po. During the same period patient was treated with TOPROL (View Toprol Review and Toprol Label ), NORVASC (View Norvasc Review and Norvasc Label ), IMDUR (View Imdur Review and Imdur Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ADVAIR HFA (View Advair Hfa Review and Advair Hfa Label ), CLARINEX (View Clarinex Review and Clarinex Label ), AVALIDE (View Avalide Review and Avalide Label ), DETROL LA (View Detrol La Review and Detrol La Label ). Patient was hospitalized.

5600346-5 | Blister, Skin Exfoliation
Patient was taking Soriatane (View Usage). Patient had the following side effects: blister, skin exfoliation on Nov 30, 2006 from UNITED STATES Additional patient health information: Female patient , 80 years of age, was diagnosed with pityriasis rubra pilaris and. Soriatane dosage: 10 Mg;qd;po. Patient was hospitalized.

5600326-X | Alanine Aminotransferase Increased, Hypercholesterolaemia, Hypertriglyceridaemia
Adverse event was reported on Nov 23, 2006 by a Male patient taking Soriatane (View Usage) (Dosage: 35 Mg;qd;po : 25mg;qd;po) was diagnosed with dermatitis and. Location: UNITED KINGDOM , 42 years of age, After Soriatane was administered, patient had the following side effects: alanine aminotransferase increased, hypercholesterolaemia, hypertriglyceridaemia. Patient was hospitalized.

5600321-0 | Cardiac Enzymes Increased, Hypoxia, Influenza
on Dec 14, 2006 Male patient from UNITED STATES , 57 years of age, weighting 627.0 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac enzymes increased, hypoxia, influenza. Soriatane dosage: 25 Mg;qd;po. During the same period patient was treated with COLCHICINE (View Colchicine Review and Colchicine Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ). Patient was hospitalized.

5600312-X | Nail Disorder
on May 03, 2007 Male patient from UNITED STATES , 59 years of age, was treated with Soriatane (View Usage). Patient had the following side effects: nail disorder. Soriatane dosage: 10 Mg;qd;po.

5600300-3 | Alanine Aminotransferase Increased
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: alanine aminotransferase increased on Aug 13, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 57 years of age, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg;qd;po : 25 Mg;qod;po : 25 Mg;qd;po. During the same period patient was treated with KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ). Patient was hospitalized.

5600296-4 | Hypercholesterolaemia, Hypertriglyceridaemia
Adverse event was reported on Jul 16, 2007 by a Female patient taking Soriatane (View Usage) (Dosage: 35 Mg;qd;po) was diagnosed with pustular psoriasis and. Location: UNITED KINGDOM , 48 years of age, Patient experienced the following unwanted or unexpected effects: hypercholesterolaemia, hypertriglyceridaemia. During the same period patient was treated with OMEGA 3 TRIGLYCERIDES (View Omega-3 Triglycerides Review and Omega-3 Triglycerides Label ).

5600271-X | Sinusitis Bacterial
on Oct 12, 2007 Male patient from UNITED KINGDOM , 33 years of age, was diagnosed with cutaneous lupus erythematosus and was treated with Soriatane (View Usage). Patient had the following side effects: sinusitis bacterial. Soriatane dosage: 25 Mg;qd;po : ;qd;po.

5600248-4 | Blood Glucose Increased, Blood Triglycerides Increased
on Sep 27, 2007 Female patient from UNITED KINGDOM , 40 years of age, weighting 172.0 lb, was diagnosed with erythrodermic psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: blood glucose increased, blood triglycerides increased. Soriatane dosage: 50 Mg;qd;po : 25 Mg;qd;po. During the same period patient was treated with SELOZOK (View Selozok Review and Selozok Label ).

5565821-0 | Pericarditis, Pneumonia
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: pericarditis, pneumonia (What is pneumonia?) on Oct 29, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 60 years of age, . Soriatane dosage: 20 Mg;qd;po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

5536688-1 | Recurrent Cancer, Vith Nerve Paralysis
Adverse event was reported on Nov 28, 2007 by a Male patient taking Soriatane (View Usage) (Dosage: 10 Mg;qd;po, 25 Mg;qd;po, 10 Mg;qd;po) was diagnosed with skin cancer (What is skin cancer?) and. Location: UNITED KINGDOM , 77 years of age, Patient had the following side effects: recurrent cancer, vith nerve paralysis.

5536414-6 | Condition Aggravated, Mycosis Fungoides, Vith Nerve Paralysis
on Nov 17, 2007 Male patient from UNITED KINGDOM , 76 years of age, weighting 158.7 lb, was diagnosed with mycosis fungoides and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: condition aggravated, mycosis fungoides, vith nerve paralysis. Soriatane dosage: 10 Mg;qd;po; 25 Mg;qd;po. Patient was hospitalized.

5528572-4 | Recurrent Cancer, Red Blood Cell Sedimentation Rate Increased, Skin Cancer, Vith Nerve Paralysis
on Nov 13, 2007 Male patient from UNITED KINGDOM , 77 years of age, was diagnosed with skin cancer (What is skin cancer?) and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: recurrent cancer, red blood cell sedimentation rate increased, skin cancer (What is skin cancer?), vith nerve paralysis. Soriatane dosage: 10 Mg;qd;po ; 25 Mg;qd;po ; 10 Mg;qd;po. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), INTRONA /05982601/ (View Introna /05982601/ Review and Introna /05982601/ Label ), CHLORAMINOPHENE (View Chloraminophene Review and Chloraminophene Label ), EPUDIX (View Epudix Review and Epudix Label ).

5528570-0 | Phlebitis, Pulmonary Embolism
Patient was taking Soriatane (View Usage). Patient had the following side effects: phlebitis, pulmonary embolism (What is pulmonary embolism?) on Nov 13, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 73 years of age, weighting 194.0 lb, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg;qd;po. During the same period patient was treated with LIPANOR (View Lipanor Review and Lipanor Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.